ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)
JPY 2041.0
(-0.34%)
JPY 2041.0
(-0.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 62.84 Billion | 60.46 Billion | 56.6 Billion | 55.18 Billion | 52.54 Billion | 46.7 Billion |
| Cost of Revenue | 32.17 Billion | 31.87 Billion | 30.25 Billion | 29.79 Billion | 28.52 Billion | 27.81 Billion |
| Gross Profit | 30.66 Billion | 28.58 Billion | 26.35 Billion | 25.38 Billion | 24.01 Billion | 18.89 Billion |
| Operating Expenses | 24.16 Billion | 23.47 Billion | 21.55 Billion | 21.77 Billion | 22.5 Billion | 17.1 Billion |
| Selling, General and Administrative Expenses | 19.43 Billion | 19.24 Billion | 17.95 Billion | 21.77 Billion | 17.59 Billion | 12.61 Billion |
| Research and Development Expenses | 4.72 Billion | 4.22 Billion | 3.59 Billion | - | 4.91 Billion | 4.49 Billion |
| Other Expenses | 1 Million | -67 Million | -73 Million | - | - | - |
| Cost and Expenses | 56.34 Billion | 55.35 Billion | 51.81 Billion | 51.57 Billion | 51.03 Billion | 44.92 Billion |
| Operating Income | 6.5 Billion | 5.1 Billion | 4.79 Billion | 3.61 Billion | 1.5 Billion | 1.78 Billion |
| Interest Expense | 40 Million | 50 Million | 56 Million | 59 Million | 64 Million | 41 Million |
| Income Tax Expense | 2.31 Billion | 1.11 Billion | 1.87 Billion | 861 Million | 252 Million | 138 Million |
| Earnings before Tax | 9.86 Billion | 5.35 Billion | 6.16 Billion | 3.57 Billion | 901 Million | 1.88 Billion |
| Net Income | 7.54 Billion | 4.23 Billion | 4.29 Billion | 2.71 Billion | 649 Million | 1.74 Billion |
| Earnings Per Share Basic | 266.49 | 150.08 | 151.22 | 95.63 | 22.94 | 61.80 |
| Earnings Per Share Diluted | 266.49 | 150.08 | 151.22 | 95.63 | 22.94 | 61.80 |
| Weighted Average Shares Outstanding | 28.31 Million | 28.23 Million | 28.37 Million | 28.37 Million | 28.28 Million | 28.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.31 Million | 28.23 Million | 28.37 Million | 28.37 Million | 28.28 Million | 28.22 Million |
| Gross Margin | 0.49 | 0.47 | 0.47 | 0.46 | 0.46 | 0.40 |
| EBIT Margin | 0.15 | 0.14 | 0.14 | 0.13 | 0.10 | 0.09 |
| Profit Margin | 0.12 | 0.07 | 0.08 | 0.05 | 0.01 | 0.04 |
| EBITDA | 9.16 Billion | 8.23 Billion | 7.68 Billion | 6.97 Billion | 5.26 Billion | 4.4 Billion |
| Earnings Before Tax Margin | 0.10 | 0.08 | 0.08 | 0.07 | 0.03 | 0.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.01 Billion | 16.35 Billion | 14.01 Billion | 62.84 Billion | 17.17 Billion | 15.62 Billion |
| Cost of Revenue | 8.28 Billion | 8.18 Billion | 6.98 Billion | 32.17 Billion | 8.73 Billion | 7.9 Billion |
| Gross Profit | 7.73 Billion | 8.17 Billion | 7.03 Billion | 30.66 Billion | 8.44 Billion | 7.72 Billion |
| Operating Expenses | 6.14 Billion | 6.41 Billion | 6.06 Billion | 24.16 Billion | 5.97 Billion | 6.37 Billion |
| Selling, General and Administrative Expenses | 6.14 Billion | 6.41 Billion | 4.76 Billion | - | 4.95 Billion | 4.9 Billion |
| Research and Development Expenses | - | 1.65 Billion | 1.29 Billion | - | 1.01 Billion | 1.46 Billion |
| Other Expenses | - | - | 23 Million | -165 Million | -60 Million | -66 Million |
| Cost and Expenses | 14.43 Billion | 14.59 Billion | 13.04 Billion | 56.34 Billion | 14.7 Billion | 14.27 Billion |
| Operating Income | 1.58 Billion | 1.75 Billion | 974 Million | 6.5 Billion | 2.47 Billion | 1.35 Billion |
| Interest Expense | 11 Million | 11 Million | 9 Million | 40 Million | 10 Million | 10 Million |
| Income Tax Expense | 213 Million | 539 Million | 254 Million | 2.31 Billion | 782 Million | 836 Million |
| Earnings before Tax | 1.49 Billion | 1.81 Billion | 1.34 Billion | 9.86 Billion | 3.11 Billion | 3.53 Billion |
| Net Income | 1.28 Billion | 1.27 Billion | 1.08 Billion | 7.54 Billion | 2.32 Billion | 2.7 Billion |
| Earnings Per Share Basic | 45.41 | 44.94 | 38.37 | - | 82.21 | 95.41 |
| Earnings Per Share Diluted | 45.41 | 44.94 | 38.37 | - | 82.21 | 95.41 |
| Weighted Average Shares Outstanding | - | 28.32 Million | 28.33 Million | 28.31 Million | 28.32 Million | 28.3 Million |
| Weighted Average Shares Outstanding (Diluted) | - | 28.32 Million | 28.33 Million | 28.31 Million | 28.32 Million | 28.3 Million |
| Gross Margin | 0.48 | 0.50 | 0.50 | 0.49 | 0.49 | 0.49 |
| EBIT Margin | 0.13 | 0.15 | 0.11 | - | 0.15 | 0.08 |
| Profit Margin | 0.08 | 0.08 | 0.08 | 0.12 | 0.14 | 0.17 |
| EBITDA | 2.13 Billion | 2.42 Billion | 1.54 Billion | - | 2.54 Billion | 1.29 Billion |
| Earnings Before Tax Margin | 0.10 | 0.11 | 0.07 | 0.10 | 0.14 | 0.09 |
TELDF
ACGI
TRNS
DRCT
ULTJ
VGLS